This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buee-Scherrer, V. Articles by Delacourte, A. Search for Related Content PubMed PubMed Citation Articles by Buee-Scherrer, V. Articles by Delacourte, A.

American Journal of Pathology, Vol 146, 924-932, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins

V Buee-Scherrer, L Buee, PR Hof, B Leveugle, C Gilles, AJ Loerzel, DP Perl and A Delacourte
INSERM U422, Lille, France.

Neurofibrillary tangles are observed in several neurodegenerative disorders including Alzheimer's disease, progressive supranuclear palsy, and amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. The major components of neurofibrillary tangles are hyperphosphorylated tau proteins that can be directly detected in brain homogenates, using immunoblotting with specific immunological probes. To investigate whether tau proteins differ biochemically among various neurodegenerative disorders, we analyzed a series of brain samples from Guamanian patients in comparison with Alzheimer's disease, progressive supranuclear palsy, and normal aging. In Alzheimer's disease, these hyperphosphorylated tau proteins are composed of a triplet referred to as tau 55, 64, and 69, whereas in progressive supranuclear palsy, neurofibrillary degeneration is characterized by a tau doublet (tau 64 and 69). In the present study, characterization of tau proteins was performed by immunoblotting, on different cortical and subcortical regions of postmortem brain specimens from Guamanian natives. In all of the cases, biochemical data were always consistent with neuropathological findings. In contrast to Alzheimer's disease patients where the tau triplet is found mostly in cortical regions, a similar triplet was strongly detected in both cortical and subcortical areas in Guamanian patients. The tau profile differed quantitatively from case to case demonstrating that the Alzheimer's disease-related tau triplet had a heterogeneous regional distribution. These data suggest that the tau triplet found in amyotrophic lateral sclerosis/parkinsonism- dementia complex of Guam is similar to that observed in Alzheimer's disease, and the regional distribution of tau proteins differs in these disorders.

This article has been cited by other articles:

				J. C. Steele and P. L. McGeer The ALS/PDC syndrome of Guam and the cycad hypothesis Neurology, May 20, 2008; 70(21): 1984 - 1990. [Abstract] [Full Text] [PDF]

				D. R. Williams, J. L. Holton, C. Strand, A. Pittman, R. de Silva, A. J. Lees, and T. Revesz Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome Brain, June 1, 2007; 130(6): 1566 - 1576. [Abstract] [Full Text] [PDF]

				A. Rametti, F. Esclaire, C. Yardin, and F. Terro Linking Alterations in Tau Phosphorylation and Cleavage during Neuronal Apoptosis J. Biol. Chem., December 24, 2004; 279(52): 54518 - 54528. [Abstract] [Full Text] [PDF]

				W. Yang, M. M. Sopper, C. Leystra-Lantz, and M. J. Strong Microtubule-associated tau protein positive neuronal and glial inclusions in ALS Neurology, December 23, 2003; 61(12): 1766 - 1773. [Abstract] [Full Text] [PDF]

				M. S. Forman, M. L. Schmidt, S. Kasturi, D. P. Perl, V. M.-Y. Lee, and J. Q. Trojanowski Tau and {alpha}-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam Am. J. Pathol., May 1, 2002; 160(5): 1725 - 1731. [Abstract] [Full Text] [PDF]

				D. Caparros-Lefebvre, N. Sergeant, A. Lees, A. Camuzat, S. Daniel, A. Lannuzel, A. Brice, E. Tolosa, A. Delacourte, and C. Duyckaerts Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy Brain, April 1, 2002; 125(4): 801 - 811. [Abstract] [Full Text] [PDF]

				D. Galasko, D. P. Salmon, U.-K. Craig, L. J. Thal, G. Schellenberg, and W. Wiederholt Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000 Neurology, January 8, 2002; 58(1): 90 - 97. [Abstract] [Full Text] [PDF]

				P. Poorkaj, D. Tsuang, E. Wijsman, E. Steinbart, R. M. Garruto, U.-K. Craig, N. H. Chapman, L. Anderson, T. D. Bird, C. C. Plato, et al. TAU as a Susceptibility Gene for Amyotropic Lateral Sclerosis-Parkinsonism Dementia Complex of Guam Arch Neurol, November 1, 2001; 58(11): 1871 - 1878. [Abstract] [Full Text] [PDF]

				J. Hardy and K. Gwinn-Hardy Genetic Classification of Primary Neurodegenerative Disease Science, November 6, 1998; 282(5391): 1075 - 1079. [Abstract] [Full Text]

				M. Hasegawa, R. A. Crowther, R. Jakes, and M. Goedert Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans. INHIBITION OF MICROTUBULE BINDING, STIMULATION OF PHOSPHORYLATION, AND FILAMENT ASSEMBLY DEPEND ON THE DEGREE OF SULFATION J. Biol. Chem., December 26, 1997; 272(52): 33118 - 33124. [Abstract] [Full Text] [PDF]